Login / Signup

Association of lung immune prognostic index with survival outcome in advanced thymic carcinoma patients treated with palliative intent chemotherapy.

Taisuke ArakiKazunari TateishiMasamichi KomatsuKei SoneharaShintaro KandaMasayuki HanaokaTomonobu Koizumi
Published in: Thoracic cancer (2022)
Our study indicates that the LIPI is a potential prognostic marker in patients with advanced or recurrent thymic carcinoma undergoing palliative chemotherapy.
Keyphrases
  • palliative care
  • locally advanced
  • advanced cancer
  • squamous cell carcinoma
  • risk assessment
  • rectal cancer
  • chemotherapy induced